OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,289,000 | +1.8% | 224,500 | -26.4% | 1.82% | +23.2% |
Q4 2019 | $1,266,000 | +50.4% | 305,000 | +17.3% | 1.47% | +39.6% |
Q3 2019 | $842,000 | +78.4% | 260,000 | +2.0% | 1.06% | +54.7% |
Q2 2019 | $472,000 | +16.0% | 255,000 | +10.9% | 0.68% | -1.7% |
Q1 2019 | $407,000 | – | 230,000 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |